Numerai Gp LLC Castle Biosciences Inc Transaction History

Numerai Gp LLC

  • $375 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$12.19 - $22.43 $294,802 - $542,447
-24,184 Reduced 35.48%
43,979 $949 Million
Q3 2023

Nov 13, 2023
BUY
$13.28 - $20.3 $12,788 - $19,548
963 Added 1.43%
68,163 $1.15 Billion
Q2 2023

Aug 11, 2023
BUY
$11.66 - $26.0 $783,552 - $1.75 Million
67,200 New
67,200 $922 Million

Others Institutions Holding CSTL

# of Institutions
201
Shares Held
24.5M
Call Options Held
303K
Put Options Held
30.3K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $752M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Numerai Gp LLC Portfolio

Follow Numerai Gp LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Numerai Gp LLC, based on Form 13F filings with the SEC.

News

Stay updated on Numerai Gp LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email